Merck’s Antiviral Could Be Just What Covid Was Waiting For

The pharmaceutical giant is making its oral antiviral drug widely available for all the world. But could Covid outsmart it? Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Nov 5, 2021

Embed this episode

Attribution link and audio player

Ready to play

Merck’s Antiviral Could Be Just What Covid Was Waiting For

0:00 9:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Talking Biotech with Dr. Kevin Folta Kevin Folta Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

Frequently Asked Questions

How long is this episode of Science, Spoken?

This episode is 9 minutes long.

When was this Science, Spoken episode published?

This episode was published on November 5, 2021.

Can I download this Science, Spoken episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!